Jens Samol

Jens Samol

Tan Tock Seng Hospital - Singapur / Singapore
Medical and Health Sciences / Hematology
AD Scientific Index ID: 4965327
person_outline Jens Samol's MOST POPULAR ARTICLES
1-) Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trialHQ Mai, QY Chen, D Chen, C Hu, K Yang, J Wen, J Li, YR Shi, F Jin, R Xu, ...Nature medicine 27 (9), 1536-1543, 20212572021
2-) Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s diseaseH Herbst, HD Foss, J Samol, I Araujo, H Klotzbach, H Krause, ...2481996
3-) Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label …S Qin, M Chen, AL Cheng, AO Kaseb, M Kudo, HC Lee, AC Yopp, J Zhou, ...The Lancet 402 (10415), 1835-1847, 20231912023
4-) Safety and tolerability of the poly (ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid …J Samol, M Ranson, E Scott, E Macpherson, J Carmichael, A Thomas, ...Investigational new drugs 30, 1493-1500, 20121762012
5-) Lymphotoxin, tumour necrosis factor and interleukin‐6 gene transcripts are present in Hodgkin and Reed‐Sternberg cells of most Hodgkin\\\'s disease casesHD Foss, H Herbst, E Oelmann, J Samol, M Grebe, T Blankenstein, ...British journal of haematology 84 (4), 627-635, 1993981993